Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites

Journal of Hepatology

Volumn 25, Issue 5, 1996, Pages 700-706

  Martinet, Jean Paul ^a   Legault, Louis ^a   Cernacek, Peter ^b   Louise, Roy ^a   Dufresne, Michel Pierre ^a   Spahr, Laurent ^a   Fenyves, Daphna ^a   Pomier Layrargues, Gilles ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cirrhosis; Endothelin; Refractory ascites; Transjugular intrahepatic portosystemic shunt

Indexed keywords

ALDOSTERONE; BIG ENDOTHELIN 1; ENDOTHELIN 1;

ADULT; AGED; ARTICLE; ASCITES; CAVA VEIN; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; PLASMA RENIN ACTIVITY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; VASODILATATION;

EID: 3843090140     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80241-8     Document Type: Article

References (32)

1. 1. Groszmann RJ. Hyperdynamic circulation of liver diseases 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-63.
2. 2. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-57.
3. 3. Jimenez W, Rodes J. Impaired responsiveness to endogenous vasoconstrictors and endothelium-derived vasoactive factors in cirrhosis. Gastroenterology 1994; 107: 1201-3.
4. 4. Bomzon A, Blendis LM. The nitric oxide and the hyperdynarnic circulation in cirrhosis. Hepatology 1994; 20: 1343-50.
5. 5. Asbert M, Ginès A, Ginès P, Jimenez J, Claria J, Salo J, Arroyo V, Rivera F, Rodes J. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993; 104: 1485-91.
6. 6. Hartleb M, Kirstetter P, Moreau R, Soupison T, Pussard E, Hadengue A, Sogni P, Gaudin C, Lebrec D. Relationship between plasma endothelin concentrations and the severity of cirrhosis. Gastroenterol Clin Biol 1994; 18: 407-12.
7. 7. Isobe H, Satoh M, Sakai H, Nawata H. Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol 1993; 17: 227-30.
8. 8. Moller S, Emmeluth C, Henriksen JH. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J Hepatol 1993; 19: 285-90.
9. 9. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992; 327: 1774-78.
10. 10. Uchihara M, Izumi N, Sato, Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992; 16: 95-99.
11. 11. Uemasa J, Matsumoto H, Kawasaki H. Increased plasma endothelin levels in patients with liver cirrhosis. Nephron 1992; 60: 380.
12. 12. Veglio F, Pinna G, Melchio R, Rabbia F, Panarelli M, Gagliardi B, et al. Plasma endothelin levels in cirrhotic subjects. J Hepatol 1992; 15: 85-7.
13. 13. Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett Jr JC, Wiesner R, Dickson ER, Krom RAF. Renal hemodynamics, urinary eicosanoids and endothelin after liver transplantation. Transplantation 1992; 54: 74-80.
14. 14. Conn HO. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology 1993; 17: 17-27.
15. 15. Lafortune M, Martinet JP, Denys A, Patriquin H, Dufresne MP, Colombato L, Pomier-Layrargues G. Short and long term hemodynamic effect of TIPS: a Doppler/manometric correlative study. Am J Roentgenol 1995; 164: 997-1002.
16. 16. Brun C. A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med 1951; 7: 955-8.
17. 17. Demassieux S, Corneille L, Lachance S, Carrière S. Determination of free and conjugated catecholamines and L-3,4-dehydroxyphenylalanine in plasma and renin: evidence of a catechol-a-methyl transferase inhibitor in uraemia. Clin Chim Acta 1981; 115: 377-91.
18. 18. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation 1992; 85: 510-7.
19. 19. Cernacek P, Stewart DJ, Levy M. Plasma endothelin-1 response to acute hypotension induced by vasodilating agents. Can J Physiol Pharmacol 1994; 72: 985-91.
20. 20. Miller W, Redfield MM, Burnett Jr JC. Integrated cardiac, renal and endocrine actions of endothelin. J Clin Invest 1989; 83:317-20.
21. 21. Hemsen A, Ahlborg G, Ottosson A, Lundberg JM. Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation to production of endothelin-1 (1-21). Reg Peptides 1995; 55: 287-97.
22. 22. Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, Ogris E, Rodler S, Wutte M, Hartter E. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993; 71: 1293-99.
23. 23. Cernacek P, Langleben D, Stewart DJ. Relationship between plasma endothelin-1 and its precursor big endothelin-1 in cardiopulmonary disease. J Vase Res 1992; 29: 95.
24. 24. Ishibashi M, Fujita M, Nagai K, Kako M, Furue H, Haku E, Osamura Y, Yamaji T. Production and secretion of endothelin by hepatocellular carcinoma. J Clin Endo Metab 1993; 76: 378-83.
25. 25. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley Jr J. Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 1988; 255: R1064-68.
26. 26. Claria J, Jimenez W, Arroyo V, Castro A, Asbert M, Ross J, Rivera F, Rodes J. Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Kidney Int 1991; 40: 182-7.
27. 27. Gerbes M, Moller S, Gulberg V, Henriksen JH. Endothelin-1 and -3 plasma concentration in patients with cirrhosis: role of splanchnic and renal passage and liver function. Hepatology 1995; 21: 735-9.
28. 28. Sanyal AJ, Gehr T, Freedman AM, Purdum PP, Schiffman ML, Luketic VA, Moore EW, Cole P, Tisnado J. Increased splanchnic endothelin-1 plays a role in the pathogenesis of ascites. Hepatology 1994; 20: 113A.
29. 29. Arroyo V, Gines P, Jimenez W, Rodès J. Ascites, renal failure, and electrolytes disorders in cirrhosis. Pathogenesis, diagnosis and treatment. In: MacIntyre N, Benhamou JP, Bircher J, Rizzeto M, Rodés J, eds. Oxford Textbook of Clinical Hepatology. Vol. 1. Oxford: Oxford University Press, 1991: 427-70.
30. 30. Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, Tsuji S, Michida T, Chen SS, Kashiwagi T, Fusamoto H, Kamada T, Sato N. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994; 19: 155-61.
31. 31. Yu PC, Kuo JS, Lin HC, Yang MCM. Effects of endothelin in portal hypertensive rats. Clin Sci 1992; 83: 165-70.
32. 32. Weitzberg E. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation. Acta Physiol Scand 1993; 611: 1-72.